Expansion of HGF Indications to Other Diseases and Fibrotic Diseases

A research and development program to expand HGF indications to diseases beyond its existing targets, including spinal cord injury, ALS, vocal fold scarring, Peyronie’s disease, peripheral neuropathy and kidney disease, by leveraging HGF’s neuroprotective and antifibrotic properties.